Patents by Inventor Hiromitsu Fuse

Hiromitsu Fuse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11936044
    Abstract: A carbon material for a non-aqueous secondary battery containing a graphite capable of occluding and releasing lithium ions, and having a cumulative pore volume at pore diameters in a range of 0.01 ?m to 1 ?m of 0.08 mL/g or more, a roundness, as determined by flow-type particle image analysis, of 0.88 or greater, and a pore diameter to particle diameter ratio (PD/d50 (%)) of 1.8 or less, the ratio being given by equation (1A): PD/d50 (%)=mode pore diameter (PD) in a pore diameter range of 0.01 ?m to 1 ?m in a pore distribution determined by mercury intrusion/volume-based average particle diameter (d50)×100 is provided.
    Type: Grant
    Filed: January 5, 2017
    Date of Patent: March 19, 2024
    Assignee: MITSUBISHI CHEMICAL CORPORATION
    Inventors: Shunsuke Yamada, Nobuyuki Ishiwatari, Satoshi Akasaka, Daigo Nagayama, Shingo Morokuma, Koichi Nishio, Iwao Soga, Hideaki Tanaka, Takashi Kameda, Tooru Fuse, Hiromitsu Ikeda
  • Publication number: 20090253789
    Abstract: There is provided an evaluation method of effect of a remedy or a therapeutic procedure for atherosclerosis directly or indirectly acting on a substance having a nature of exacerbating atherosclerosis (particularly, a protein) and being present in an atherosclerotic lesion to improve the atherosclerotic lesion, which comprises performing an evaluation by, regarding respective atherosclerotic lesion samples of a mammal origin collected from an administration- or application-group of the remedy or therapeutic procedure, and from a non-administration- or non-application-group, comparing a value of one group corresponding to strength of an atherosclerosis-exacerbating activity of the substance (for example, a pharmacological activity such as an enzyme activity) present in the sample and corrected by an amount of a correction marker in the atherosclerotic lesion, with that of the other group, said amount of the correction maker varying correlating with an amount of the substance in the atherosclerotic lesion and b
    Type: Application
    Filed: November 10, 2006
    Publication date: October 8, 2009
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Kazuki Kubo, Hiromitsu Fuse, Koji Yamamoto, Makiko Itasaka, Satoshi Nishimura
  • Publication number: 20090082303
    Abstract: The present invention relates to a prophylactic/therapeutic agent for atherosclerosis comprising GM3 synthase inhibitor or inhibitor for expression of GM3 synthase gene, a diagnostic product for atherosclerosis comprising antibody to GM3 synthase, a method of diagnosis for atherosclerosis using antibody to GM3 synthase and others, an use of GM3 or GM3 synthase for diagnostic marker of atherosclerosis, and the like.
    Type: Application
    Filed: November 20, 2008
    Publication date: March 26, 2009
    Inventors: Hiromitsu FUSE, Sachio Shibata, Yoshio Taniyama
  • Publication number: 20070248591
    Abstract: The present invention provides preventive/therapeutic agents for arteriosclerosis, diabetes mellitus, etc., which comprise glucosylceramide or (and) lactosylceramide synthase inhibitors, expression inhibitors for glucosylceramide or (and) lactosylceramide synthase genes, methods and kits for screening the preventive/therapeutic agents, and so on.
    Type: Application
    Filed: September 6, 2005
    Publication date: October 25, 2007
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Hiromitsu Fuse, Sachio Shibata, Hideaki Tojo
  • Publication number: 20070161586
    Abstract: The present invention relates to a prophylactic/therapeutic agent for atherosclerosis comprising GM3 synthase inhibitor or inhibitor for expression of GM3 synthase gene, a diagnostic product for atherosclerosis comprising antibody to GM3 synthase, a method of diagnosis for atherosclerosis using antibody to GM3 synthase and others, an use of GM3 or GM3 synthase for diagnostic marker of atherosclerosis, and the like.
    Type: Application
    Filed: January 14, 2005
    Publication date: July 12, 2007
    Inventors: Hiromitsu Fuse, Sachio Shibata, Yoshio Taniyama
  • Patent number: 6982348
    Abstract: The present invention provides a pharmaceutical agent having cholesteryl ester transfer protein inhibitory action and useful as a blood lipid lowering agent and the like. The present invention relates to a compound represented by the formula wherein Ar1 is an aromatic ring group optionally having substituents, Ar2 is an aromatic ring group having substituents, OR? is an optionally protected hydroxyl group, R is an acyl group, R? is a hydrogen atom or a hydrocarbon group optionally having substituents, or a salt thereof, and a pharmaceutical composition containing a compound of the formula (I) or a salt thereof or a prodrug thereof.
    Type: Grant
    Filed: January 25, 2002
    Date of Patent: January 3, 2006
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Masakuni Kori, Kazumasa Hamamura, Hiromitsu Fuse, Toshihiro Yamamoto
  • Publication number: 20040127574
    Abstract: The present invention provides a pharmaceutical agent having cholesteryl ester transfer protein inhibitory action and useful as a blood lipid lowering agent and the like.
    Type: Application
    Filed: July 25, 2003
    Publication date: July 1, 2004
    Inventors: Masakuni Kori, Kazumasa Hamamura, Hiromitsu Fuse, Toshihiro Yamamoto
  • Publication number: 20030139616
    Abstract: It is intended to find an efficient method of searching for drugs affecting the cholesteryl ester cycle and establish a system of efficiently searching for defoaming agents or regression agents artherosclerotic lesion and a system of searching for therapeutic agents remedies for atherosclerosis with a mechanism different from publicly known ones.
    Type: Application
    Filed: October 22, 2002
    Publication date: July 24, 2003
    Inventors: Ryuichi Tozawa, Hiromitsu Fuse, Shunbun Kita, Masahira Nakamura